PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Candesartan attenuates ischemic brain edema and protects the blood-brain barrier integrity from ischemia/reperfusion injury in rats.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25326022 ↗2014Reported benefit

Candesartan attenuates ischemic brain edema and protects the blood-brain barrier integrity from ischemia/reperfusion injury in rats.

RatIschaemia-reperfusionCerebral (MCAO/stroke)Sprague-DawleyMalen = Three main groups with 32 rats per group; experiments perfo…Intravenous0.1 mg/kg (non-hypotensive dose)One hour before induction of ischaemia

Model: Transient focal cerebral ischaemia by intraluminal middle cerebral artery occlusion with a 3-0 nylon filament for 60 min followed by 24 h reperfusion

A single non-hypotensive intravenous dose of candesartan one hour before middle cerebral artery occlusion improved neurological scores and reduced infarct volume by 54.9 per cent, oedema by 59.2 per cent and Evans blue extravasation by 54.9 per cent without altering arterial blood pressure.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.93. Machine-extracted fields require source verification.